Serum TRACP 5b Is a Useful Marker for Monitoring Alendronate Treatment: Comparison With Other Markers of Bone Turnover-Reference-Cited by-同舟云学术

Serum TRACP 5b Is a Useful Marker for Monitoring Alendronate Treatment: Comparison With Other Markers of Bone Turnover

Published:2005-04-04 Issue:10 Volume:20 Page:1804-1812
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Nenonen Arja,Cheng Sulin,Ivaska Kaisa K,Alatalo Sari L,Lehtimäki Terho,Schmidt-Gayk Heinrich,Uusi-Rasi Kirsti,Heinonen Ari,Kannus Pekka,Sievänen Harri,Vuori Ilkka,Väänänen H Kalervo,Halleen Jussi M

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference38 articles.

1. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function;Minkin;Calcif Tissue Int,1982

2. Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissues;Yaziji;Am J Clin Pathol,1995

3. Tartrate-resistant acid phosphatase (Acp 5): Identification in diverse human tissues and dendritic cells;Hayman;J Histochem Cytochem,2001

4. Purification and properties of the native form of the purple acid phosphatase from bovine spleen;Orlando;Biochemistry,1993

5. Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases;Ljusberg;Biochem J,1999

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Denosumab with Romosozumab in the Treatment of Male Osteoporosis: A Retrospective Cohort Study;2024-06-20

2. Prognostic value of serum tartrate‑resistant acid phosphatase‑5b for bone metastasis in patients with resectable breast cancer;Oncology Letters;2024-04-05

3. Morinda officinalis polysaccharide promotes the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells via microRNA-210-3p/scavenger receptor class A member 3;Journal of Investigative Medicine;2024-03-04

4. Temporal patterns of osteoclast formation and activity following withdrawal of RANKL inhibition;Journal of Bone and Mineral Research;2024-02-04

5. An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications: a case–control study;Osteoporosis International;2024-01-31